Biocept Inc (NASDAQ:BIOC) investors are having a rough morning after the cancer diagnostic test maker announced that it intends to offer and sell 9,100,000 shares of its …
Biocept Inc (NASDAQ:BIOC), a molecular diagnostics company commercializing and developing blood-based liquid biopsies to provide information to physicians to improve the diagnosis and …
Yesterday, Biocept Inc (NASDAQ:BIOC) announced news of solidifying a new agreement with Teneovita Medical Innovations for a full distribution range of liquid biopsy testing …
Biocept Inc (NASDAQ:BIOC), a molecular diagnostics company commercializing and developing assays for liquid biopsies to improve the detection and treatment of cancer, announces an …
Biocept Inc (NASDAQ:BIOC), a molecular diagnostics company commercializing and developing liquid biopsies to improve the detection and treatment of cancer, announces that it …
Biocept Inc (NASDAQ:BIOC), a molecular diagnostics company commercializing and developing assays for liquid biopsies to improve the detection and treatment of cancer, announces …
Biocept Inc (NASDAQ:BIOC), a molecular diagnostics company commercializing and developing biomarkers in liquid biopsies to improve the detection and treatment of cancer, and …
Biocept Inc (NASDAQ:BIOC), a molecular diagnostics company commercializing and developing liquid biopsies to improve the detection and treatment of cancer, today announced the …
Canadian Solar Inc. (NASDAQ:CSIQ) plummeted nearly -11% in pre-market trading down to $21.
